title: Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab.
authors.affiliation: Children's & Women's Health Centre of British Columbia, University of British Columbia, Vancouver2Child & Family Research Institute, Vancouver, British Columbia3Division of Neonatology, Department of Pediatrics, University of British Columbia, Vancouver.
authors.forename: Pascal M
authors.initials: PM
authors.lastname: Lavoie
authors.affiliation: Children's & Women's Health Centre of British Columbia, University of British Columbia, Vancouver3Division of Neonatology, Department of Pediatrics, University of British Columbia, Vancouver.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Solimano
authors.affiliation: Department of Pediatrics, University of Victoria, Victoria, British Columbia.
authors.forename: Richard
authors.initials: R
authors.lastname: Taylor
authors.affiliation: Children's & Women's Health Centre of British Columbia, University of British Columbia, Vancouver5Department of Pharmacy, University of British Columbia, Vancouver.
authors.forename: Eddie
authors.initials: E
authors.lastname: Kwan
authors.affiliation: Children's & Women's Health Centre of British Columbia, University of British Columbia, Vancouver.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Claydon
authors.affiliation: Children's & Women's Health Centre of British Columbia, University of British Columbia, Vancouver2Child & Family Research Institute, Vancouver, British Columbia6Division of Allergy and Clinical Immunology, University of British Columbia, Vancouver.
authors.forename: Stuart E
authors.initials: SE
authors.lastname: Turvey
authors.affiliation: Children's & Women's Health Centre of British Columbia, University of British Columbia, Vancouver7Canadian Center for Vaccinology, Halifax, Nova Scotia8Sidra Medical and Research Center, Doha, Qatar.
authors.forename: Nico
authors.initials: N
authors.lastname: Marr
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D000069455:Palivizumab / Q000008:administration & dosage*; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses / Q000276:immunology*
chemical_list: D000998:Antiviral Agents; D000069455:Palivizumab